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Pharmacologic
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Pregnancy
Lori Keough
Heidi Collins Fant
asia

Neonatal Implications
of Substance Use Treatment
During Pregnancy
I

am writing in response to “Pharmacologic
Treatment of Opioid Addiction During
Pregnancy” by Keough and Fantasia (2017). The
article nicely compares and summarizes the use
of methadone and buprenorphine to treat substance use in pregnant women. I was dismayed,
however, by the sections regarding neonatal considerations and breastfeeding, which contained
some problematic assertions and some inaccurate conclusions.
The use of the term addicted to refer to an
infant of a woman who is using opioids is inappropriate. The literature clearly diﬀerentiates
between addiction and dependence; infants
are incapable of the psychological activities
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that define the compulsive nature of addiction.
Infants are accurately described in the literature as being born dependent on the substance
they have been exposed to. More concerning,
however, is the statement that because of the
immaturity of all systems, premature infants
have more severe withdrawal symptoms. In fact,
the exact opposite is true. Although the exact
mechanisms for this muted response are not yet
delineated in the literature, the Kocherlakota
article (2014) cited by the authors is clear in this
fact.
Lastly, the paragraph that discusses breastfeeding may be misleading and is not well referenced. Although it is true that breastfeeding is
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the standard of care, the amount of methadone
excreted in breast milk is consistently found to
be small and unlikely to cause withdrawal at
cessation. The evidence regarding buprenorphine and breastfeeding is limited; however,
it also appears that only small quantities of
buprenorphine are expressed into breast milk.
Guidelines from the Academy of Breastfeeding
Medicine (Reece-Stremtan, Marinelli, & Academy of Breastfeeding Medicine, 2015) clarify
the literature on these substances and support
breastfeeding as something that will ameliorate symptoms of neonatal abstinence syndrome
and may shorten duration of medical treatment
required of a neonate. However, the most recent
literature does not explain the exact mechanism
and points to the act of breastfeeding rather
than the breast milk itself as a potential supportive agent. The rate and duration of breastfeeding for substance-exposed mothers are lower
than for mothers who are not substance exposed
(Wachman, Byun, & Phillip, 2010; Welle-Strand
et al., 2013), making exclusive breastfeeding
until introduction of solid food unlikely. There
is a strong need for more research in this area.
I appreciate the authors sharing important
information on this most challenging of topics,
and I hope that these comments may serve to
clarify and update the information presented on
the neonatal side of the maternal–infant dyad.

Michele Savin, MSN, NNP-BC
Philadelphia, PA

References
Keough, L., & Fantasia, H. C. (2017). Pharmacologic treatment of opioid addiction during
pregnancy. Nursing for Women’s Health, 21(1),
34–44. doi:10.1016/j.nwh.2016.12.010
Kocherlakota, P. (2014). Neonatal abstinence
syndrome. Pediatrics, 134(2), e547. doi:10.1542/
peds.2013-3524
Reece-Stremtan, S., Marinelli, K. A., & Academy
of Breastfeeding Medicine. (2015). ABM clinical
protocol #21: Guidelines for breastfeeding and
substance use or substance use disorder, revised
2015. Breastfeeding Medicine, 10(3), 135–141.
doi:10.1089/bfm.2015.9992

Breastfeeding rates among mothers of infants
with neonatal abstinence syndrome. Breastfeeding Medicine, 5(4), 159–164. doi:10.1089/
bfm.2009.0079
Welle-Strand, G. K., Skurtveit, S., Jansson, L. M.,
Bakstad, B., Bjark, L., & Ravndal, E. (2013).
Breastfeeding reduces the need for withdrawal
treatment in opioid-exposed infants. Acta Pædiatrica, 102, 1060–1066. doi:10.1111/apa.12378

Authors’ Response
Thanks to Ms. Savin for her thoughtful review
of our article. We appreciate the complicated
medical and social implications opioid addiction brings to women, particularly those of
childbearing age, and to their families. Even
more important is the expertise neonatal nurse
practitioners can provide to their patients who
are vulnerable and unable to care for themselves, as is the case with infants.
The purpose of this article was to present an
overview of what is currently known about the
pharmacologic treatment of opioid addiction
during pregnancy. We applaud Ms. Savin’s careful attention to the neonatal component of the
maternal–infant dyad. Adding to the complexities of treatment for both women and infants is
the often observational and retrospective nature
of the research in this area, which carries inherent limits in the development of evidence-based
interventions and applicability to clinical practice. The complicated social factors and resulting
confounding variables within this population,
coupled with significant ethical implications,
add to the variability noted in the literature
and contribute to the challenges of conducting
research in this area.
We are grateful to Ms. Savin for her clinical
expertise, perspectives on this important topic,
and commitment to the health of women and
their infants.

Lori Keough, PhD, MEd, FNP-BC,
PMHNP-BC
Lowell, MA
Heidi Collins Fantasia, PhD, RN,
WHNP-BC
Winthrop, MA
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